News

Pfizer says its coronavirus vaccine works

Hello, It’s a big day: Pfizer just said that its vaccine is more than 90% effective at preventing COVID-19, an incredibly important milestone in confronting the pandemic. Pfizer and its partner BioNTech are the first to report results on how effective a vaccine is, and it’s sending Pfizer’s stock — […]
Pfizer says its coronavirus vaccine works
News

An election week for the history books

Welcome to Business Insider ‘ s daily healthcare newsletter , your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hello, I’m not sure what I thought election week was going to look like amid a pandemic, but I do […]
An election week for the history books
News

The promise of the first new Alzheimer’s drug in nearly 2 decades

Welcome to Business Insider ‘ s daily healthcare newsletter , your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hello, While we wait to hear more about the results of the presidential election, here’s the latest in healthcare news. […]
The promise of the first new Alzheimer’s drug in nearly 2 decades
News

Dispensed: One Medical’s stock market debut, a playbook for the gene therapy business, and a startup quietly powering the companies that ship prescriptions to your door

Hello, Welcome to Dispensed, Business Insider’s weekly healthcare newsletter, in which we’re keeping a close eye on One Medical stock price as it starts trading Friday after pricing at the bottom of its range last night. With earnings season in full swing, it’s been a busy week. Are you new […]
Dispensed: One Medical’s stock market debut, a playbook for the gene therapy business, and a startup quietly powering the companies that ship prescriptions to your door
Markets

Biogen climbs as profits surge 72%, prompting the firm to boost 2019 guidance

Biogen jumped about 2% in early trading on Tuesday after beating estimates and raising guidance for the rest of 2019. The company’s multiple sclerosis therapy led the company’s 72% revenue growth in the second quarter. The treatment brought in $US100 million more than analysts’ consensus estimate. The earnings beat comes […]
Biogen climbs as profits surge 72%, prompting the firm to boost 2019 guidance
Markets

Biogen is crashing after scrapping its late-stage Alzheimer’s drug trials

Biogen and the Japanese pharmaceutical company Eisai said Thursday they would discontinue late-stage Alzheimer’s drug trials. Shares of Biogen crashed more than 25% in pre-market trading. Watch Biogen trade live. Biogen shares crashed more than 25% in pre-market trading Thursday after the biotech company and Eisai, a Japanese pharmaceutical company, […]
Biogen is crashing after scrapping its late-stage Alzheimer’s drug trials
« Previous Page